Table 4 Frequency of drug related adverse effects among patients in each group
Adverse effects N (%) | Group | P- value | |
|---|---|---|---|
Mirtazapine (N = 34) | Placebo (N = 33) | ||
Drowsiness | 12 (35.3%) | 3 (9.1%) | 0.01 |
Dizziness | 6 (17.6%) | 2 (6.1%) | 0.25 |
Nausea | 5 (14.7%) | 2 (6.1%) | 0.43 |
Dry mouth | 9 (26.5%) | 2 (6.1%) | 0.04 |
Fatigue | 10 (29.4%) | 2 (6.1%) | 0.02 |
Headache | 4 (11.8%) | 1 (3.0%) | 0.36 |
Increased appetite | 11 (32.4%) | 2 (6.1%) | 0.01 |
Weight gain | 8 (23.5%) | 1 (3.0%) | 0.03 |